FDA Initiates TEMPO Pilot with Dexcom for Digital Health Devices
The FDA has chosen Dexcom, Inc. as the first participant in its TEMPO pilot, aiming to improve chronic disease management under Medicare. This selection opens new procurement avenues for contractors focused on digital health technologies and data analytics that support innovative healthcare delivery.